ADLINOD 25MG

Adlinod 25 Capsule is indicated for the treatment of multiple myeloma, myelodysplastic syndromes, deletion 5q MDS, mantle cell lymphoma, and follicular lymphoma. Multiple myeloma is a type of cancer affecting plasma cells, leading to abnormal antibody production and damage to bones.

Adlinod 25 Capsule contains ‘lenalidomide’, which enhances the body’s immune response and directly targets cancer cells.

You may encounter some common side effects, including fatigue, constipation, diarrhea, muscle cramps, nausea, headaches, upper respiratory tract infections, dizziness, shortness of breath, and weakness. If you experience any of these side effects persistently, consult your doctor.

Notify your doctor if you have an allergy to Adlinod 25 Capsule or any of its ingredients. It is advisable to avoid using Adlinod 25 Capsule if you are pregnant or breastfeeding. This medication may lead to dizziness, drowsiness, fatigue, and blurred vision; therefore, drive only when you feel fully alert. Both men and women using Adlinod 25 Capsule should employ effective contraception.